mianserin has been researched along with CJD (Creutzfeldt-Jakob Disease) in 2 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koponen, H | 2 |
| Honkonen, S | 2 |
| Partanen, J | 2 |
| Riekkinen, PJ | 2 |
2 other studies available for mianserin and CJD (Creutzfeldt-Jakob Disease)
| Article | Year |
|---|---|
[Symptoms of Creutzfeldt-Jakob disease during mianserin therapy].
Topics: Aged; Creutzfeldt-Jakob Syndrome; Depression; Epilepsy; Epilepsy, Tonic-Clonic; Female; Humans; Male | 1991 |
Epileptic attack, delirium, and periodic complexes in the EEG during mianserin treatment.
Topics: Aged; Creutzfeldt-Jakob Syndrome; Delirium; Depressive Disorder; Diagnosis, Differential; Electroenc | 1991 |